头颈癌光子、质子及质子-光子联合放疗的计划比较——从固定束流线到弧旋照射
本研究在5例头颈癌患者的计划CT及多次重复CT上,比较质子-光子联合放疗(CPPT)、单纯调强质子治疗(IMPT)与调强放疗(IMRT)的计划质量。CPPT不适应性修改时靶区覆盖不足(平均V95%=88.4%),适应性修改后可恢复至平均V95%=95.5%。增加质子束自由度可提升CPPT计划质量并降低口干和吞咽困难正常组织并发症概率。
要点
- CPPT不适应性修改时靶区覆盖不足(平均V95%=88.4%),适应性修改后可恢复至平均V95%=95.5%。
- CPPT增加质子束自由度(FHB/龙门架/弧旋)可提升计划质量并降低口干和吞咽困难NTCP。
- 作者结论认为CPPT需适应性治疗,且光子成分大幅减少,计划质量提升与成本的平衡需进一步确定。
核心结论
- 头颈癌CPPT需要适应性治疗;增加质子束自由度(使用龙门架或直立位患者)可提升计划质量,但光子成分大幅减少,计划质量提升与成本之间的平衡需进一步确定。
研究设计与样本
- 研究纳入5例有计划CT和多次(4-7次)重复CT的头颈癌患者,在计划CT上优化CPPT(光子与质子通量同时优化)、IMPT和IMRT计划,并在每张重复CT上重新计算和再优化;CPPT和IMPT比较固定水平质子束流线(FHB)、类龙门架和类弧旋等不同质子束自由度的计划。
主要发现
- CPPT不适应性修改时靶区覆盖不足(平均V95%=88.4%),适应性修改后靶区(平均V95%=95.5%)和危及器官可恢复初始计划质量。
- CPPT增加质子束灵活性可提升计划质量并降低口干和吞咽困难正常组织并发症概率。
- 与IMRT相比,口干NTCP平均降低:CPPT FHB为-2.7%、CPPT Gantry为-3.4%、CPPT Arc为-5.0%。
- 与IMRT相比,口干NTCP平均变化:IMPT FHB为+0.8%、IMPT Gantry为-0.9%、IMPT Arc为-4.3%。
局限性
- 作者结论指出CPPT需适应性治疗,且光子成分大幅减少,计划质量提升与成本之间的平衡需进一步确定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: This study investigates whether combined proton-photon therapy (CPPT) improves treatment plan quality compared to single-modality intensity-modulated radiation therapy (IMRT) or intensity-modulated proton therapy (IMPT) for head and neck cancer (HNC) patients. Different proton beam arrangements for CPPT and IMPT are compared, which could be of specific interest concerning potential future upright-positioned treatments. Furthermore, it is evaluated if CPPT benefits remain under inter-fractional anatomical changes for HNC treatments. MATERIAL AND METHODS: Five HNC patients with a planning CT and multiple (4-7) repeated CTs were studied. CPPT with simultaneously optimized photon and proton fluence, single-modality IMPT, and IMRT treatment plans were optimized on the planning CT and then recalculated and reoptimized on each repeated CT. For CPPT and IMPT, plans with different degrees of freedom for the proton beams were optimized. Fixed horizontal proton beam line (FHB), gantry-like, and arc-like plans were compared. RESULTS: The target coverage for CPPT without adaptation is insufficient (average V95%=88.4 %), while adapted plans can recover the initial treatment plan quality for target (average V95%=95.5 %) and organs-at-risk. CPPT with increased proton beam flexibility increases plan quality and reduces normal tissue complication probability of Xerostomia and Dysphagia. On average, Xerostomia NTCP reductions compared to IMRT are -2.7 %/-3.4 %/-5.0 % for CPPT FHB/CPPT Gantry/CPPT Arc. The differences for IMPT FHB/IMPT Gantry/IMPT Arc are + 0.8 %/-0.9 %/-4.3 %. CONCLUSION: CPPT for HNC needs adaptive treatments. Increasing proton beam flexibility in CPPT, either by using a gantry or an upright-positioned patient, improves treatment plan quality. However, the photon component is substantially reduced, therefore, the balance between improved plan quality and costs must be further determined.
引用
- Amstutz F, Krcek R, Bachtiary B, et al. Treatment planning comparison for head and neck cancer between photon, proton, and combined proton-photon therapy - From a fixed beam line to an arc. Radiother Oncol. 2023. PMID: 37913953. doi:10.1016/j.radonc.2023.109973
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。